We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Inovio Pharmaceuticals Plunged 20% Today
Shares of biotech company Inovio Pharmaceuticals (INO - Free Report) fell sharply on Tuesday after announcing updates to its Covid-19 vaccine candidate, INO-4800. INO plunged 20% during the day before climbing back a bit into close.
Inovio said its early-stage clinical study showed positive results and that the vaccine was considered safe and well-tolerated; 94% of the 40 participants “demonstrated overall immune responses.”
However, investors were hoping for more concrete information about the efficacy of the vaccine, and Inovio didn’t provide any information about how many patients produced antibodies. The antibodies are key: they prevent infection by the coronavirus.
Inovio hopes to begin a phase 2/3 clinical study this summer after getting FDA approval.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>